Statistics for Safety and immunogenicity after a 30month boost of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 MF59 vaccine boost HVTN 100 A phase 12 randomized doubleblind placebocontrolled trial
Total visits
| views | |
|---|---|
| Safety and immunogenicity after a 30month boost of a subtype C ALVACHIV vCP2438 vaccine prime plus bivalent subtype C gp120 MF59 vaccine boost HVTN 100 A phase 12 randomized doubleblind placebocontrolled trial | 1 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| Journal Article.pdf | 1 |